Paul Klotman, M.D., FACP, began serving as president, CEO and executive dean of Baylor College of Medicine on September 1, 2010. He received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his medicine and nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member, rising to the rank of associate professor of medicine before moving to the National Institutes of Health in 1988 where he became chief of the Molecular Medicine Section in the Laboratory of Developmental Biology.

Dr. Klotman’s research has been a blend of both basic and clinical research in molecular virology and AIDS pathogenesis. He is the author of more than 200 publications and he has been a visiting professor and lecturer internationally in the field of HIV pathogenesis. He has been elected to both the American Society of Clinical Investigation and the Association of American Physicians. He is on the editorial boards of journals both in the United States and in Europe and he has served on and chaired numerous study sections including those from the NIH, the American Heart Association and the National Kidney Foundation.

Dr. Klotman serves on the scientific advisory boards of biotech, pharmaceutical and healthcare companies. He also serves on the board of several companies including those with interests in natural resources and conservation.

At Baylor College of Medicine, he oversees the only private health science university in the Greater Southwest, with research funding of nearly $400 million. The medical school is ranked as one of the top 20 for research by U.S. News & World Report. The School of Allied Health Sciences is among the best 10 in the nation and the Graduate School of Biomedical Sciences is rated in the top 5 percent. The College is ranked first among all Texas colleges, universities and medical schools in federal funding for research and development, and is ranked second in federally funded research expenditures by the National Science Foundation.

C. Kent Osborne, M.D., received his A.B. and M.D. degrees from the University ofMissouri, both with honors. He completed his internship and residency at Johns HopkinsHospital in 1974 and spent three years as a clinical associate at the Medicine Branch,Breast Cancer Section of the National Cancer Institute in Bethesda, Maryland. In 1977,he took his first faculty position at The University of Texas Health Science Center at SanAntonio, where he rose to the rank of professor and became director of the Division ofMedical Oncology in 1992. He came to Houston in 1999 as director of the College’s breastcancer program. In 2005, he was named director of the new Dan L Duncan CancerCenter at Baylor College of Medicine, which achieved comprehensive designation fromthe National Cancer Institute in 2015 while under his leadership.

Dr. Osborne is a physician-scientist who has focused on breast cancer his entire career. His research interests include understanding the biology of breast cancer and developing new treatment approaches for the disease. He currently is principal investigator of the Baylor Breast Cancer Specialized Program of Research Excellence grant, and he holds the Dudley and Tina Sharp Chair for Cancer Research at Baylor College of Medicine.

Among his awards are the Komen Foundation Award, the Brinker International Award for Breast Cancer Research, the European Institute of Oncology Annual Breast Cancer Award and the Bonadonna Award for Breast Cancer Research.

THE PARTNERSHIP FOR BAYLOR COLLEGE OF MEDICINE EDUCATIONAL LUNCHEON

1

FUTURE OF HEALTHCARE AT BAYLOR COLLEGE OF MEDICINE

PAUL KLOTMAN, M.D., FACP President & CEOExecutive Dean

C. KENT OSBORNE, M.D.Director,Dan L Duncan ComprehensiveCancer Center

SEPTEMBER 20, 2016

2 3

NOTES

FUTURE OF HEALTHCARE Baylor College of Medicine’s dedication to furthering its core mission areas of patient care, community outreach, research and education allows the institution to evolve and influence the future of medicine. We commit ourselves to providing our faculty and learners alike with the diverse perspectives, collaborative environments and top-tier resources necessary for success. As part of our strategic road map leading us into 2020, we follow a set objectives we refer to as DIRECTS.

Discover the fundamentals of human disease and health.

Invest in the human and technological resources necessary for innovation.

Reach the community locally, nationally and globally.

Educate generations of life-long learners dedicated to excellence in biomedical research, patient care and education.

Create the learning health delivery system of the future.

Translate our discoveries into new diagnostics, treatments and cures.

Sustain an operationally excellent and fiscally stable platform.

The faculty, staff and learners at Baylor eagerly anticipate witnessing how their passion and hard work will resonate in medicine in the years to come.

THE DAN L DUNCAN COMPREHENSIVE CANCER CENTER

The Dan L Duncan Comprehensive Cancer Center began life as the Cancer Center at Baylor College of Medicine in 2002 and changed its name to the Dan L Duncan Cancer Center four years later thanks to a generous donation from Dan L Duncan. In 2015, the Center received the comprehensive designation from the National Cancer Institute. This honor represents an institution’s commitment to providing more than just world-class patient care. It also symbolizes dedication to clinical trial participation, intensive research, education and community outreach.

The Dan L Duncan Comprehensive Cancer Center is one of only three centers in Texas with the comprehensive designation and is one of 47 across the United States. The Center has organized cancer relevant research at BCM into seven coherent programs to enhance collaboration between members from different disciplines and training, including breast cancer, cancer biology, cancer cell and gene therapy, cancer evolution, cancer prevention and population sciences, nuclear receptor biology and pediatric oncology. In addition, the Center houses working groups for brain, breast, gastrointestinal, gynecological, head and neck, hematologic, liver, lung and thoracic, pancreatic, pediatric and urologic and prostate cancers. The Center also supports 13 shared resources that enhance the science of all its members.

The Center is charged with enhancing collaboration among members based in almost every department and center at BCM, including the Human Genome Sequencing Center. Care and clinical trials are delivered at our affiliated hospitals, Ben Taub Hospital, Baylor St. Luke’s Medical Center, Michael E. DeBakey Veterans Affairs Medical Center and Texas Children’s Hospital.

THE FUTURE OF THE DAN L DUNCAN COMPREHENSIVE CANCER CENTER

The Center must now pivot its focus to more fully develop its clinical care and clinical research programs to reach its utmost potential. That vision hinges on the development of an identifiable cancer center clinical space at the Baylor St. Luke’s Medical Center on the McNair Campus and on a larger strategy of a regional and national presence with other CHI hospitals. This new home is being designed to support patient-centered, disease-oriented, multidisciplinary teams modeled on the Lester and Sue Smith Breast Center to deliver exceptional patient care equal to the promise of its research enterprise. It will ultimately bring together all cancer patient care activities in a single location and act as the hub to anchor regional and national programs with CHI.

Multidisciplinary teams of physician and administrative leaders already have been working for the last six months to lay out the space needs for every cancer type. This effort will create stronger physician and staff teams in a space specifically designed to facilitate collaboration while creating a more integrated and supportive environment for patients. Over the next several months, the Center will be working with architects to translate its ideas into tangible realities.

At the same time, the Center also will strengthen and maintain its commitments to the underserved community, including veterans and children with cancer. This next stage in the development of the Center will require a new set of investments and assurances other than the ones that have been so pivotal to advancing the Dan L Duncan Cancer Center to its current state of national recognition and excellence.

There are currently 468 members of the Dan L Duncan Comprehensive Cancer Center. Dr. Osborne has assembled an impressive team of seasoned leaders to help with organizing and operating the Center. All of them played a significant part in securing comprehensive status.

These leaders include David Poplack, M.D., director of the Texas Children’s Cancer Center, who serves as deputy director and Maria Jibaja-Weiss, M.Ed., Ed.D., serves as director of the Office of Outreach and Health Disparities.

Associate directors are responsible for different aspects of the Center’s services and include Bert O’Malley, M.D. (basic research), Helen Heslop, M.D., D.Sc., and Martha Mims, M.D., Ph.D. (clinical research), Steven Curley, M.D. (clinical affairs), Melissa Bondy, Ph.D. (cancerprevention and population science), Dean Edwards,Ph.D. (research infrastructure), Suzanne Fuqua, Ph.D.,and Jason Yustein, M.D., Ph.D., (education), MatthewEllis, M.D., Ph.D. (translational research) and Ted Yank,M.H.A. (administration).

The executive committee, which is chaired by Dr. Osborne, is composed of all the aforementioned individuals, as well as at-large members Sue Hilsenbeck, Ph.D., and Malcolm Brenner, M.D., M.B., C.H.B.

LEADERSHIP: DAN L DUNCAN COMPREHENSIVE CANCER CENTER

The Dan L Duncan Comprehensive Cancer Center leadership team. Not pictured: Jason Yustein, M.D., Ph.D., Matthew Ellis, M.D., Ph.D., Susan Hilsenbeck, Ph.D. and Malcolm Brenner, M.D., Ph.D.

JOINT VENTURE PARTNERS

AFFILIATED HOSPITALS

MAJOR ACADEMIC PARTNERS

4

JOIN THE PARTNERSHIP OR RENEW YOUR MEMBERSHIP NOWYou won’t want to miss any of the exciting educational and social events we have planned for The Partnership for Baylor College of Medicine. Join or renew your membership, invite your friends and start having fun today!

All members enjoy: Invitations to all Partnership events, educational

programs and tours. Updates on cutting-edge health news from the

College. Opportunities to meet some of the best minds in

medicine today.

MEMBER LEVELSSupporting Member – annual dues $50Patron Member – annual dues $200Endowed Lifetime Member – one time fee of $1,500All membership fees are fully tax deductible.

For more information about membership, please contact partnership@bcm.edu or 713.798.5460.

SPECIAL THANKS TO OUR SPONSORS

Benefactor - $5,000

Supporter - $2,500

Grand Rounds Supporter - $2,500Amy and Lloyd Kirchner

For more information on becoming a sponsor of The Partnership, please

call Anne Fried at 713.798.6104.

Mobile 713.806.2633Email mvinson@marthaturner.com

Margaret VinsonREALTOR® Associate - Circle of Excellence

UPCOMING EVENTS AT BAYLOR COLLEGE OF MEDICINE

BCM WELLNESS 5K RACE/WALKSaturday, October 22Check in opens at 7:30 a.m.Race begins at 8:15 a.m.1 Baylor Plaza, 77030

NEIMAN MARCUS STILETTO STRUTBenefiting the Lester and Sue Smith Breast CenterFriday, October 2810 a.m. until noonNeiman Marcus Galleria2600 Post Oak Blvd., 77056

DIVA U SPEAKER SERIESBenefiting the Center for Medical Ethics and Health PolicyMultiple datesnoonGrappino di Nino Restaurant2817 West Dallas St., 77019For more information about the speakers to be featured, please visit www.bcm.edu/ethics/speakerseries

LET ME DOWN EASYPresented by the Center for Medical Ethics and Health PolicyTuesday, January 17, 20177 p.m.Wortham Center501 Texas Ave., 77002

For more information on any of these events, please visit: https://www.bcm.edu/giving/upcoming-events

EDUCATIONAL LUNCHEON SERIES11:30 a.m.–1 p.m. Junior League of HoustonSeptember 20, 2016 Future of Healthcare at

Baylor College of Medicine

November 15, 2016 Counting Sheep Instead of Sleep?

January 17, 2017 What Did You Say? Having Problems Hearing?

March 21, 2017 Fighting the “Big C...Cancer”

May 16, 2017 The Aging Family Member: Dealing with the Issues

GRAND ROUNDS TOURS Dates and times to be determined.October 2016 Human Genome

Sequencing Center

December 2016 Hematology-Oncology Lab part of the Margaret M. and Albert B. Alkek Department of Medicine

February 2017 An Exploration of Aphrodisiac Tastes with the Center for Reproductive Medicine

April 2017 Center for Sleep Medicine

ROB TODD